Bionano Genomics Stock In The News
| BNGO Stock | USD 3.47 0.15 4.52% |
Our overall analysis of Bionano Genomics' news coverage and content from conventional and social sources shows investors' bearish mood towards Bionano Genomics. The specific impact of Bionano Genomics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Bionano Genomics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Bionano Genomics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Bionano Genomics Backtesting and Bionano Genomics Hype Analysis. To learn how to invest in Bionano Stock, please use our How to Invest in Bionano Genomics guide.
Bionano |
Bionano Genomics Today Top News and Investor Outlook
Bionano Genomics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Bionano and other traded companies coverage with news coverage. We help investors stay connected with Bionano headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Bionano Stock performance. Please note that trading solely based on the Bionano Genomics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Bionano Genomics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Bionano earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Bionano Genomics that are available to investors today. That information is available publicly through Bionano media outlets and privately through word of mouth or via Bionano internal channels. However, regardless of the origin, that massive amount of Bionano data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bionano Genomics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bionano Genomics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bionano Genomics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bionano Genomics alpha.
Bionano Largest EPS Surprises
Earnings surprises can significantly impact Bionano Genomics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-11-04 | 2021-09-30 | -0.06 | -0.07 | -0.01 | 16 | ||
2021-08-04 | 2021-06-30 | -0.05 | -0.06 | -0.01 | 20 | ||
2023-03-09 | 2022-12-31 | -0.11 | -0.13 | -0.02 | 18 | ||
2022-08-04 | 2022-06-30 | -0.09 | -0.11 | -0.02 | 22 | ||
2022-03-01 | 2021-12-31 | -0.06 | -0.08 | -0.02 | 33 | ||
2020-11-12 | 2020-09-30 | -0.05 | -0.08 | -0.03 | 60 |
Bionano Genomics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Bionano Genomics Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
13th of March 2025
Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key... at gurufocus.com
11th of February 2025
Slammed 62 percent Bionano Genomics, Inc. Screens Well Here But There Might Be A Catch at simplywall.st
3rd of February 2025
Bionano Genomics, Inc. Sees Large Decrease in Short Interest - MarketBeat at news.google.com
28th of January 2025
Bionano Genomics Shares Gap Down - Time to Sell - MarketBeat at news.google.com
23rd of January 2025
Bionano Genomics stock hits 52-week low at 0.17 amid market challenges - Investing.com at news.google.com
14th of January 2025
Bionano Announces Use of OGM in Preimplantation Genetic Testing as Part of Successful Live... at finance.yahoo.com
13th of January 2025
Bionano reports Q4 preliminary revenue in range of 7.9 million to 8.1 million at seekingalpha.com
7th of January 2025
Bionano Announces Publication Showing that OGM Identifies Variant that Indicates Use of Pr... at gurufocus.com
23rd of December 2024
Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outpe... at finance.yahoo.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bionano Genomics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bionano Genomics' short interest history, or implied volatility extrapolated from Bionano Genomics options trading.
Check out Bionano Genomics Backtesting and Bionano Genomics Hype Analysis. To learn how to invest in Bionano Stock, please use our How to Invest in Bionano Genomics guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bionano Genomics. If investors know Bionano will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bionano Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (138.00) | Revenue Per Share | Quarterly Revenue Growth (0.35) | Return On Assets | Return On Equity |
The market value of Bionano Genomics is measured differently than its book value, which is the value of Bionano that is recorded on the company's balance sheet. Investors also form their own opinion of Bionano Genomics' value that differs from its market value or its book value, called intrinsic value, which is Bionano Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bionano Genomics' market value can be influenced by many factors that don't directly affect Bionano Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bionano Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bionano Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bionano Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.